The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock

Female age has been known to define reproductive outcome since antiquity; attempts to improve ovarian function may be considered against a sociocultural landscape that foreshadows current practice. Ancient writs heralded the unlikely event of an older woman conceiving as nothing less than miraculous...

Full description

Bibliographic Details
Main Author: E. Scott Sills
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Medicines
Subjects:
Online Access:https://www.mdpi.com/2305-6320/8/6/29
_version_ 1827690382315487232
author E. Scott Sills
author_facet E. Scott Sills
author_sort E. Scott Sills
collection DOAJ
description Female age has been known to define reproductive outcome since antiquity; attempts to improve ovarian function may be considered against a sociocultural landscape that foreshadows current practice. Ancient writs heralded the unlikely event of an older woman conceiving as nothing less than miraculous. Always deeply personal and sometimes dynastically pivotal, the goal of achieving pregnancy often engaged elite healers or revered clerics for help. The sorrow of defeat became a potent motif of barrenness or miscarriage lamented in art, music, and literature. Less well known is that rejuvenation practices from the 1900s were not confined to gynecology, as older men also eagerly pursued methods to turn back their biological clock. This interest coalesced within the nascent field of endocrinology, then an emerging specialty. The modern era of molecular science is now offering proof-of-concept evidence to address the once intractable problem of low or absent ovarian reserve. Yet, ovarian rejuvenation by platelet-rich plasma (PRP) originates from a heritage shared with both hormone replacement therapy (HRT) and sex reassignment surgery. These therapeutic ancestors later developed into allied, but now distinct, clinical fields. Here, current iterations of intraovarian PRP are discussed with historical and cultural precursors centering on cell and tissue regenerative effects. Intraovarian PRP thus shows promise for women in menopause as an alternative to conventional HRT, and to those seeking pregnancy—either with advanced reproductive technologies or as unassisted conceptions.
first_indexed 2024-03-10T10:37:27Z
format Article
id doaj.art-c944b1e425124f5fb61ff4cfabab1f2d
institution Directory Open Access Journal
issn 2305-6320
language English
last_indexed 2024-03-10T10:37:27Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Medicines
spelling doaj.art-c944b1e425124f5fb61ff4cfabab1f2d2023-11-21T23:14:49ZengMDPI AGMedicines2305-63202021-06-01862910.3390/medicines8060029The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological ClockE. Scott Sills0Plasma Research Section, FertiGen CAG/Regenerative Biology Group, San Clemente, CA 92673, USAFemale age has been known to define reproductive outcome since antiquity; attempts to improve ovarian function may be considered against a sociocultural landscape that foreshadows current practice. Ancient writs heralded the unlikely event of an older woman conceiving as nothing less than miraculous. Always deeply personal and sometimes dynastically pivotal, the goal of achieving pregnancy often engaged elite healers or revered clerics for help. The sorrow of defeat became a potent motif of barrenness or miscarriage lamented in art, music, and literature. Less well known is that rejuvenation practices from the 1900s were not confined to gynecology, as older men also eagerly pursued methods to turn back their biological clock. This interest coalesced within the nascent field of endocrinology, then an emerging specialty. The modern era of molecular science is now offering proof-of-concept evidence to address the once intractable problem of low or absent ovarian reserve. Yet, ovarian rejuvenation by platelet-rich plasma (PRP) originates from a heritage shared with both hormone replacement therapy (HRT) and sex reassignment surgery. These therapeutic ancestors later developed into allied, but now distinct, clinical fields. Here, current iterations of intraovarian PRP are discussed with historical and cultural precursors centering on cell and tissue regenerative effects. Intraovarian PRP thus shows promise for women in menopause as an alternative to conventional HRT, and to those seeking pregnancy—either with advanced reproductive technologies or as unassisted conceptions.https://www.mdpi.com/2305-6320/8/6/29fertilityplateletscytokinesangiogenesismenopause
spellingShingle E. Scott Sills
The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
Medicines
fertility
platelets
cytokines
angiogenesis
menopause
title The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
title_full The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
title_fullStr The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
title_full_unstemmed The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
title_short The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
title_sort scientific and cultural journey to ovarian rejuvenation background barriers and beyond the biological clock
topic fertility
platelets
cytokines
angiogenesis
menopause
url https://www.mdpi.com/2305-6320/8/6/29
work_keys_str_mv AT escottsills thescientificandculturaljourneytoovarianrejuvenationbackgroundbarriersandbeyondthebiologicalclock
AT escottsills scientificandculturaljourneytoovarianrejuvenationbackgroundbarriersandbeyondthebiologicalclock